BeOne Medicines (ONC) Total Current Liabilities (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Total Current Liabilities data on file, last reported at $1.8 billion in Q1 2026.

• On a quarterly basis, Total Current Liabilities fell 8.68% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 8.68% decrease from a year earlier, with the FY2025 full-year figure at $1.8 billion, down 17.43% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $1.8 billion, down from $1.8 billion in the prior quarter.
• Over the last five years, Total Current Liabilities for ONC reached as high as $2.4 billion in Q3 2025 and fell as low as $917.4 million in Q4 2022.
• Historically, Total Current Liabilities has averaged $1.7 billion across 5 years, with a median of $1.8 billion in 2026.
• Across the five-year window, Total Current Liabilities plunged 42.65% in 2022 and surged 97.32% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $917.4 million in 2022, then jumped by 97.32% to $1.8 billion in 2023, then increased by 22.36% to $2.2 billion in 2024, then retreated by 17.43% to $1.8 billion in 2025, then declined by 0.95% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $2.4 billion in Q3 2025.